On July 10, 2025, a decision of the National Union of Health Insurance Funds regarding the update of the CCAM Classification of Medical Procedures was published. The update includes the provisional registration of one procedure code for transrectal HIFU destruction of prostate lesions and changes to indications and billing notes for several existing codes. The update takes effect on September 1, 2025.

On July 10, 2025, the National Association of Statutory Health Insurance Physicians (KBV) announced that the extended Evaluation Committee has adopted the framework specifications for calculating Hybrid DRGs for 2026.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Sustainability Publications Digest. In a recent publication, Bobini et al. conducted an international survey of health technology assessment (HTA) organizations across 20 countries to explore global progress in integrating environmental sustainability into HTA.

MTRC has released a White Paper titled "Clinical evidence requirements for the “Orderly Introduction of Medical Technologies” process in Sweden". This report provides an opportunity to learn about the evidence requirements of Sweden's Dental and Pharmaceutical Benefits Agency (TLV) and the Medical Technology Product (MTP) Council in relation to the national process of Orderly Introduction of medical technologies. White Paper outlines the key points and recommendations for the MedTech industry informed by three HTA reports with positive recommendations.

On July 9, 2025, the NHS Cancer Programme granted £14.4 million to seven projects through the third Innovation Open Call. The projects aimed to fast-track the implementation of proven, late-stage innovations for the early detection and diagnosis of cancer.

In July 2025, the Finnish classification of procedures (THL) was updated. Forty-five procedure codes concerning ophthalmology, radiology, e-Health, radiotherapy, nuclear medicine, interventional radiology, and some other fields were introduced to come into force on January 1, 2026.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Geuzinge et al. revised the Dutch healthcare economic evaluation guideline, drawing on recommendations from an independent national HTA committee.

The new Swiss outpatient billing system, comprising the TARDOC catalog of individual service tariffs and outpatient flat rates, approved by the Federal Council, is expected to take effect on January 1, 2026. On July 15, 2025, the Organization for Outpatient Physician Tariffs (OAAT AG) requested pre-launch adjustments to this system concerning hospital emergency and non-physician services, combination therapy in cancer treatment, wound care, and pathology services.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Barker et al. presented the revised JBI critical appraisal tool for cohort studies.

MTRC has released a White Paper titled "Evidence requirements for AI-based technologies in Europe." This Paper reviews evidence requirements for AI-based technologies as identified in five recent European HTA assessments, including urgent-care fracture detection (NICE, UK), hyperacute stroke imaging (NICE, UK), colonoscopic polyp detection (Danish Health Technology Council), and breast cancer screening programs (OSTEBA in Spain and SBU in Sweden).

In July 2025, the Common Catalog of Genetic and Genomic Tests of Spain’s National Health System was updated. Two sections with a total of 25 new genetic tests were introduced for ENT diseases and non-hepatic gastrointestinal diseases.

On July 14, 2025, NICE published a HealthTech program manual. A new program will combine the former Medical Technologies Evaluation and Diagnostic Assessment programs and the Interventional Procedures program. The HealthTech program will produce two types of guidance: HealthTech guidance for devices, diagnostics, and digital products, and Interventional Procedures guidance. A life-cycle approach will be utilized for assessment and recommendations: early use, routine use, and existing use (late stage assessment).